| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.8M | -52.6% |
| Cost of Revenue | $11.4M | -23.1% |
| Gross Profit | -$5.6M | -112.5% |
| R&D Expense | $9.6M | -22.0% |
| SG&A Expense | $17.2M | -7.3% |
| Operating Income | -$74.0M | -41.4% |
| Pre-tax Income | -$73.5M | -46.6% |
| Net Income | -$73.5M | -46.6% |
| EPS (Basic) | -$1.08 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.2M | -31.5% |
| Accounts Receivable | $1.6M | -57.9% |
| Inventory | $4.8M | -46.5% |
| Current Assets | $26.7M | -35.6% |
| Total Assets | $39.4M | -54.3% |
| Current Liabilities | $2.1M | -59.5% |
| Total Liabilities | $2.1M | -60.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.7M | +9.7% |
| Capital Expenditures | $1.4M | -74.5% |
| Investing Cash Flow | -$2.9M | +84.9% |
| Financing Cash Flow | $18.3M | +4168.5% |
| Free Cash Flow | -$25.1M | +20.6% |
| -36.7% |
| EPS (Diluted) | -$1.08 | -36.7% |
| Stockholders' Equity |
| $37.3M |
| -53.8% |